Cipla: Not the Best Among Peers but Catching up Fast, Keep on Watchlist.
Cipla Ltd (CIPLA IN) is India’s third largest pharmaceutical company. Cipla’s common stock is not the cheapest among peers, looking at the forward...
259 Views
Aurobindo Pharma: Analysis and Valuation
Aurobindo Pharma Ltd (ARBP IN) is the 5th largest pharmaceutical company in India by market cap and revenue. It is the 7th largest pharmaceutical...
204 Views
No Trump Cards for This Risk
This Insight is an update from Generic Drug Antitrust Inquiry: A Primer. Several generic drug companies caught up in government investigations into...
240 Views
Key Drivers of Asia's Healthcare Sector
From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...
3.4k Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...
4.8k Views